Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schneider, D. T.
Right arrow Articles by Göbel, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schneider, D. T.
Right arrow Articles by Göbel, U.
Journal of Clinical Oncology, Vol 18, Issue 4 (February), 2000: 832
© 2000 American Society for Clinical Oncology

Primary Mediastinal Germ Cell Tumors in Children and Adolescents: Results of the German Cooperative Protocols MAKEI 83/86, 89, and 96

By Dominik T. Schneider, Gabriele Calaminus, Harald Reinhard, Peter Gutjahr, Bernhard Kremens, Dieter Harms, Ulrich Göbel

From the Department of Pediatric Hematology and Oncology, Heinrich-Heine-University, Düsseldorf; Department of Pediatric Hematology and Oncology, University of Homburg-Saar, Homburg-Saar; Department of Pediatric Hematology and Oncology, Johannes-Gutenberg-University, Mainz; Department of Pediatric Hematology and Oncology, University of Essen, Essen; and Institute of Pathology, Department of Pediatric Pathology, Christian-Albrechts-University, Kiel, Germany.

Address reprint requests to Dominik T. Schneider, MD, Department of Pediatric Hematology and Oncology, Heinrich-Heine-University, Medical Center, Moorenstr 5, D-40225 Duesseldorf, Germany; email makei{at}med.uni-duesseldorf.de

PURPOSE: To evaluate children and adolescents with primary mediastinal teratoma and malignant germ cell tumors (GCTs).

PATIENTS AND METHODS: Forty-seven patients from the German nontesticular GCT studies were analyzed (median age, 2.5 years; range, neonate to 17 years). Teratoma (n = 21) were resected, and no adjuvant treatment was given. Malignant GCTs (n = 26) were treated with cisplatin-based chemotherapy and resection. Three of 26 patients underwent radiotherapy.

RESULTS: In all patients with teratoma, tumor markers were normal. Surgery of teratoma was complete in 17 of 21 patients and microscopically incomplete in four of 21 patients, and we observed no relapse after a median follow-up of 29 months. In 23 of 26 patients with malignant GCTs, alpha-fetoprotein and/or beta-human chorionic gonadotropin were elevated. Twelve of 26 patients received adjuvant chemotherapy after initial resection, which was complete in six of 12 patients, whereas delayed resection after preoperative chemotherapy was complete in 10 of 11 patients (P = .03). Four of six patients underwent second-look thoracotomy after incomplete primary surgery. Three of 26 patients did not undergo tumor resection. The final completeness of resection was the strongest prognostic indicator (event-free survival [EFS], 0.94 ± 0.06 v 0.42 ± 0.33; P < .002). Local stage and distant metastases were not prognostically significant at the .05 level. For all malignant GCTs, the 5-year survival rate was 0.87 ± 0.05 (median follow-up, 51 months), with an EFS of 0.83 ± 0.05.

CONCLUSION: The prognosis of mediastinal teratoma is excellent after complete or microscopically incomplete resection. In children with malignant GCT, the prognosis is favorable with a therapeutic strategy of delayed resection after preoperative chemotherapy. In most children, the diagnosis can be based on elevated tumor markers and imaging. Biopsy is indicated in nonsecreting GCT.

The Maligne Keimzelltumoren studies are supported by the Deutsche Krebshilfe eV, Bonn, Germany.




This article has been cited by other articles:


Home page
JCOHome page
B. Cushing, R. Giller, J. W. Cullen, N. M. Marina, S. J. Lauer, T. A. Olson, P. C. Rogers, P. Colombani, F. Rescorla, D. F. Billmire, et al.
Randomized Comparison of Combination Chemotherapy With Etoposide, Bleomycin, and Either High-Dose or Standard-Dose Cisplatin in Children and Adolescents With High-Risk Malignant Germ Cell Tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882
J. Clin. Oncol., July 1, 2004; 22(13): 2691 - 2700.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J. Schwabe, G. Calaminus, W. Vorhoff, V. Engelbrecht, B. P. Hauffa, and U. Gobel
Sexual precocity and recurrent {beta}-human chorionic gonadotropin upsurges preceding the diagnosis of a malignant mediastinal germ-cell tumor in a 9-year-old boy
Ann. Onc., June 1, 2002; 13(6): 975 - 977.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. T. Schneider, R. Wessalowski, G. Calaminus, H. Pape, M. Bamberg, J. Engert, K. Waag, H. Gadner, and U. Gobel
Treatment of Recurrent Malignant Sacrococcygeal Germ Cell Tumors: Analysis of 22 Patients Registered in the German Protocols MAKEI 83/86, 89, and 96
J. Clin. Oncol., April 1, 2001; 19(7): 1951 - 1960.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2000 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online